Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment. (Q48700718)

14 February 2018

title

Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment. (English)

1 reference

14 February 2018

0 references

Tarazi FI

1

1 reference

14 February 2018

Florijn WJ

series ordinal

2

1 reference

14 February 2018

Creese I

series ordinal

3

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

14 February 2018

published in

Neuroscience

1 reference

14 February 2018

volume

78

1 reference

14 February 2018

issue

4

1 reference

14 February 2018

page(s)

985-996

1 reference

14 February 2018

The functional anatomy of basal ganglia disorders

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Brain dopamine receptors: a primer on their current status, basic and clinical

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Molecular diversity of the dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Expression of rat striatal D1 and D2 dopamine receptor mRNAs: ontogenetic and pharmacological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Effects of chronic discontinuous and continuous treatment of rats with a dopamine D1 receptor antagonist (NNC-756)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

[3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine D1 receptor antagonism in schizophrenia: is there reduced risk of extrapyramidal side-effects?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Long-term treatment with haloperidol or clozapine does not affect dopamine D4 receptors in rat frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

D2-family receptor distribution in human postmortem tissue: an autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Distribution of D5 dopamine receptor mRNA in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

[3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

[3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine D4 receptors elevated in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Molecular biology of dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Genomic structure and tissue distribution of the mouse dopamine D4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Mechanisms of signal transduction at the dopamine D2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Autoradiographic distribution of [3H]YM-09151-2, a high-affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

10.1016/S0306-4522(96)00631-8

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9174067

1 reference

14 February 2018